145 related articles for article (PubMed ID: 30048768)
1. Bleeding and splenectomy in Wiskott-Aldrich syndrome: A single-centre experience.
Rivers E; Worth A; Thrasher AJ; Burns SO
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1042-1044.e1. PubMed ID: 30048768
[No Abstract] [Full Text] [Related]
2. The Wiskott-Aldrich syndrome.
Ormerod AD
Int J Dermatol; 1985 Mar; 24(2):77-81. PubMed ID: 3886570
[No Abstract] [Full Text] [Related]
3. High-dose immunoglobulin therapy of Wiskott-Aldrich syndrome.
Wodzinski MA; Lilleyman JS
Pediatr Hematol Oncol; 1987; 4(4):345-8. PubMed ID: 3152941
[No Abstract] [Full Text] [Related]
4. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.
Mullen CA; Anderson KD; Blaese RM
Blood; 1993 Nov; 82(10):2961-6. PubMed ID: 8219187
[TBL] [Abstract][Full Text] [Related]
5. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe thrombocytopenia with IL-11 in children with Wiskott-Aldrich syndrome.
Braithwaite K; Abu-Ghosh A; Anderson L; Cairo MS
J Pediatr Hematol Oncol; 2002 May; 24(4):323-6. PubMed ID: 11972106
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
Lum LG; Tubergen DG; Corash L; Blaese RM
N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient.
Hongeng S; Pakakasama S; Hathirat P; Chaisiripoomkere W; Ungkanont A
Bone Marrow Transplant; 1999 Aug; 24(4):445-6. PubMed ID: 10467341
[No Abstract] [Full Text] [Related]
12. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
Krisiukeniene A; Sitkauskiene B; Sakalauskas R
Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
[TBL] [Abstract][Full Text] [Related]
13. Non-lethal Wiskott-Aldrich syndrome: atopic dermatitis-like lesions persist after splenectomy.
Feliciani C; Castellaneta M; Amatetti M; Morelli F; Toto P; Coscione G; Pour Mohammad S; Amerio P
Int J Dermatol; 2000 May; 39(5):398-400. PubMed ID: 10849137
[No Abstract] [Full Text] [Related]
14. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
[TBL] [Abstract][Full Text] [Related]
15. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
16. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago.
Lang P; Klingebiel T; Schumm M; Handgretinger R; Greil J; Beck JF; Niethammer D; Bader P
Bone Marrow Transplant; 2004 Apr; 33(8):879-80. PubMed ID: 14743191
[No Abstract] [Full Text] [Related]
17. Significant and persistent improvement of thrombocytopenia after splenectomy in an adult with the Wiskott-Aldrich Syndrome and intra-cerebral bleeding.
Gaspoz JM; Waldvogel F; Cornu P; Gugler E; Dayer JM
Am J Hematol; 1995 Mar; 48(3):182-5. PubMed ID: 7864026
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous thrombosis of hepatic aneurysms in an infant with Wiskott-Aldrich syndrome.
Merlini L; Hanquinet S; Gungor T; Ozsahin H
Pediatr Hematol Oncol; 2009 Jun; 26(4):261-6. PubMed ID: 19437328
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
